Picture BIO Deutschland German Corona Special 2021 Digital 650x80px
Document › Details

UDG Healthcare plc. (11/26/19). "Press Release: UDG Healthcare Acquires U.S. Strategic Communications Agency".

Region Region San Diego, CA
  Country United States (USA)
Organisations Organisation Ashfield Healthcare Communications Group Ltd.
  Group UDG Healthcare (Group)
  Organisation 2 Canale Communications Inc. (CanaleComm)
  Group UDG Healthcare (Group)
Products Product public relations / investor relations / marcom (services)
Index term Index term Canale Communications–UDG Healthcare: investment, 201911 acquisition of CanaleComm that will join Ashfield Healthcare Communcations Group
Person Person Jacobson, Matt (UDG Healthcare 201911 Executive Director of Ashfield Healthcare Communications)

UDG Healthcare plc, a leading international healthcare services provider, is pleased to announce the acquisition of Canale Communications, an award-winning San Diego-based strategic communications agency, providing corporate communications, public relations, investor relations, and creative services to life sciences companies including biotech, biopharma, digital health and genomics. CanaleComm will join Ashfield Healthcare Communications, UDG Healthcare’s global agency network that works with clients at the intersections of science, data, and creativity to commercialise molecules, markets, and brands.

Founded in 2010, CanaleComm employs a team of nearly 30 experts who intimately understand the life science industry landscape. The team is uniquely equipped to translate their clients’ business objectives into communications strategy that builds reputation, enhances visibility, and captivates the audiences that matter most. The company has worked with over 300 biotech, medical device, digital health, and pharmaceutical companies.

Commenting on the acquisition, Founder and CEO Carin Canale-Theakston said: “The acquisition of CanaleComm by UDG Healthcare and the joining of forces with Ashfield Healthcare Communications’ network is the ideal platform as we look to grow a more robust service offering for our clients. UDG Healthcare’s focus on life sciences, complementary offering, and strong employee-first culture were all extremely attractive to CanaleComm. We are looking forward to being able to continue the strong growth trajectory that we have been on over the last nine years and being part of the broader UDG Healthcare family.”

The acquisition continues to expand Ashfield Healthcare Communications’ service offering, capabilities, and client base by providing corporate communications, public relations, investor relations, and creative services to biotech and life sciences companies at virtually every stage of development.

“We are thrilled CanaleComm has joined Ashfield Healthcare Communications,” commented Matt Jacobson, Executive Director of Ashfield Healthcare Communications. “They bring a distinct and highly complementary service offering for our healthcare and life sciences clients and further strengthen our U.S. footprint especially in the west coast biotech industry.”

About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 8,500 people with operations in 26 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across two divisions: Ashfield and Sharp.

Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of the-art facilities in the US and Europe.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250. For more information, please go to:

About Canale Communications

Canale Communications is a strategic communications and creative firm exclusively serving the life science and healthcare industries. The company has worked with more than 300 biotech, health tech, and pharmaceutical companies at virtually every stage of development. The firm specializes in corporate communications, public relations, investor communications, website development, creative services, content creation and distribution, and social media. Canale Communications primarily serves clients headquartered in the biotech hubs of San Diego and the San Francisco Bay Area, and also extends to other life science markets that are home to some of the hottest new biotech and digital health companies. Visit to learn more.

Record changed: 2021-03-28


Picture BIO Deutschland German Corona Special 2021 Digital 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top